COMMUNIQUÉS West-GlobeNewswire

Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
17/09/2026
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today [...]
Quinze étudiants atteints d’une MII reçoivent des bourses pour poursuivre leurs études
17/09/2026
Le programme de bourses d’études MII d’AbbVie souligne 15 ans de reconnaissance de la résilience et des ambitions des étudiants qui vivent avec la maladie de Crohn ou la colite ulcéreuse à travers le Canada TORONTO, 17 [...]
Fifteen Students Living With IBD Receive Scholarships to Help Pursue Their Education
17/09/2026
The AbbVie IBD Scholarship Program marks 15 years of recognizing the resilience and ambitions of students across Canada living with Crohn’s disease or ulcerative colitis TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Crohn [...]
TimelyCare Unveils "Connected Care for Every Student," with an AI Well-being Guide as an Easier First Step
17/09/2026
Built for every student, including those who would never book an appointment, the model pairs an AI well-being guide with human coaching and licensed clinical care. Fort Worth, TX, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
17/09/2026
Combined company to focus on developing first-in-class next-generation medicines for cardioendocrine diseases Marea has multiple late-stage clinical product candidates: MAR001/005 for severe hypertriglyceridemia (sHTG) [...]
LQpay Introduces Custom AI Assistant LuQ, Bringing AI Directly into the Healthcare Payments Experience
17/09/2026
LuQ marks the first step in LQpay’s broader strategy to leverage AI and emerging technologies to simplify workflows, enhance automation and help healthcare organizations work more efficiently PLANTATION, Fla., Sept. 17 [...]
San Diego-based Park Mental Health Treatment Facility Highlights Importance of Mental Wellness Recognized as Year-Round Healthcare Priority
17/09/2026
Mental Wellness Requires Preventive Approach, Too San Diego, CA., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Each year, specific months are dedicated to bringing awareness to various mental health topics; depression, PTSD, [...]
San Diego-based Shoreline Recovery Center Encourages Compassionate Support for those Struggling with Addiction
17/09/2026
From Overdose Awareness to Recovery San Diego, CA., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Overdose is a common and serious risk for individuals with a substance use disorder. It is also preventable, with the simple act of [...]
Live Oaks Wellness Addiction Treatment Facility Strengthens Marin County Recovery Community through Outreach, Education and Service
17/09/2026
Recent ‘Recover or Die’ Charity Event Raises Awareness for Substance Addiction NOVATO, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- When it comes to increasing responsible conversation around addiction and reducing the [...]
Novo: CHMP recommends EU approval of FREHEMGO® (denecimig), the first factor VIIIa mimetic offering monthly, once every two weeks and weekly dosing in a pre-filled pen, for the treatment of haemophilia A
17/09/2026
FREHEMGO® (denecimig) has been recommended by CHMP for approval in the EU for the treatment of haemophilia A (congenital FVIII deficiency), with or without inhibitors for adults and children FREHEMGO® is the first [...]
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH
17/09/2026
RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH The 2026 Award, open to early career investigators from around the world, was dedicated to advancing research in [...]
Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award
17/09/2026
Global GIL Recognition Spotlights Apeloa’s End-to-End "API + Drug Product" Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated Markets SHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
Two Herbalists Spent Six Years Formulating an Energy Bar. Here's Why It Took That Long.
17/09/2026
ILA launches Chocolate and Peanut adaptogenic energy bars, the first products from a formulation process co-founders Amy Saleh and Eileen Brantley refused to rush ATLANTA, GA , Sept. 17, 2026 (GLOBE NEWSWIRE) -- Most [...]
Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team
17/09/2026
Latest publication adds to growing body of clinical evidence supporting hybrid IVUS-OCT imaging in complex coronary procedures Chief Technology Officer Amandeep Thind to lead continued innovation TORONTO, Sept. 17, 2026 [...]
Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026
17/09/2026
NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced [...]
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
17/09/2026
U.S. Centers for Disease Control and Prevention (CDC) Reports a Significant Year-Over-Year Increase in Nationwide Rabies Exposures and Rabies Immunoglobulin Utilization KedRAB is One of Only Two FDA-Approved Anti-Rabies [...]
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
17/09/2026
Payment of Special Dividend Contingent upon Closing of the Pending Merger Transaction RICHMOND, Va., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) (“Indivior”) today announced that its [...]
Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
17/09/2026
Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026 FDA will determine the resubmission classification and establish the applicable review timeline [...]
MitoRx Therapeutics to present new data on MTRX31, its novel mitochondrial-targeted small molecule, at the 62nd EASD Annual Meeting 2026
17/09/2026
Oral presentation on durable and better quality weight loss induced by MTRX31 in an industry-standard preclinical model of obesity, with new data detailing its differentiated mode of action Structural biology and other [...]

Pages